Matthew C. Pickering

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 126 publications

Mapping the plasma proteomic architecture of systemic lupus erythematosus.

Mapping the plasma proteomic architecture of systemic lupus erythematosus.

Journal: JCI insight

Published: June 02, 2026

SEISMIC: A multi-stakeholder summit addressing access issues in diagnosis and treatment of C3G nephropathy and IC-MPGN.

SEISMIC: A multi-stakeholder summit addressing access issues in diagnosis and treatment of C3G nephropathy and IC-MPGN.

Journal: Kidney international

Published: April 06, 2026

Mapping the plasma proteomic architecture of systemic lupus erythematosus.

Mapping the plasma proteomic architecture of systemic lupus erythematosus.

Journal: JCI insight

Published: March 18, 2026

A novel fusion protein reduces kidney complement in experimental C3 glomerulopathy.

A novel fusion protein reduces kidney complement in experimental C3 glomerulopathy.

Journal: Clinical and experimental immunology

Published: December 05, 2025

Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.

Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.

Journal: The New England journal of medicine

Published: December 03, 2025

Delphi Consensus on Surrogate End Points in C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis.

Delphi Consensus on Surrogate End Points in C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis.

Journal: Kidney international reports

Published: October 13, 2025

Current and Emerging Therapies for C3 Glomerulopathy and Primary (Idiopathic) Immune Complex Membranoproliferative Glomerulonephritis.

Current and Emerging Therapies for C3 Glomerulopathy and Primary (Idiopathic) Immune Complex Membranoproliferative Glomerulonephritis.

Journal: Kidney international reports

Published: July 09, 2025

Single-Cell Level Characterization of B Cell Depletion and Repopulation Following Rituximab in Systemic Lupus Erythematosus.

Single-Cell Level Characterization of B Cell Depletion and Repopulation Following Rituximab in Systemic Lupus Erythematosus.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: May 23, 2025

Complement and kidney diseases: unlocking the opportunity of targeted treatments for glomerular diseases, including IgA nephropathy.

Complement and kidney diseases: unlocking the opportunity of targeted treatments for glomerular diseases, including IgA nephropathy.

Journal: Pediatric nephrology (Berlin, Germany)

Published: May 13, 2025

High sensitivity measurement of circulating interferon proteins in systemic lupus erythematosus.

High sensitivity measurement of circulating interferon proteins in systemic lupus erythematosus.

Journal: Clinical and experimental rheumatology

Published: May 01, 2025

Annexin A2 interferes with complement regulation within the glomerulus.

Annexin A2 interferes with complement regulation within the glomerulus.

Journal: The Journal of biological chemistry

Published: March 28, 2025

Clinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative GN.

Clinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative GN.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: January 16, 2025

Showing 1-12 of 126

Last Updated: 09/26/2026